MT1621
- Generic Name
- MT1621
- Drug Type
- Small Molecule
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Zogenix MDS, Inc.
- Registration Number
- NCT04581733
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath